Approval · Notice of Compliance 13893 · 2012
TEVA-OXYCODONE CR: Notice of Compliance 13893
Issued November 26, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13893
- Date
- November 26, 2012
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic
- Canadian reference product
- OXYCONTIN (Purdue Pharma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-OXYCODONE CR | 02291266 | Cancelled Pre Market |
| TEVA-OXYCODONE CR | 02291274 | Cancelled Pre Market |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 40 MG per TAB
- OXYCODONE HYDROCHLORIDE 80 MG per TAB